Latest Headlines
-
Novel small molecule potently attenuates neuroinflammation in brain and glial cells
Limiting neuroinflammation may represent a promising new approach to treat neurological diseases driven by neuroinflammation, such as stroke, spinal cord injury and neuropathic pain. -
Using translational pharmacogenomics to boost race-conscious medicine
Pharmacogenomics has become a valuable tool for optimizing treatments and is poised to play an increasing role in clinical care. -
Virtually all Alabamians could benefit from gene-based drug prescribing, statewide study finds
Analyzing gene sequencing data and prescriptions for more than 3,300 participants in the Alabama Genomic Health Initiative, UAB researchers estimate 98.6% of Alabamians have actionable genotypes and “a significant proportion are currently prescribed affected medications.” -
Gaston helps epileptic community during pandemic; finds meaningful ways to give back
Tyler Gaston, M.D., assistant professor in the Department of Neurology, found a meaningful way to give back to her patients during the COVID-19 pandemic by joining the Alabama Professional Advisory Board for the Epilepsy Foundation. -
Exercise, sleep and cognition are linked in Parkinson's disease. A new study aims to personalize prescriptions.
Research by Amy Amara, M.D., Ph.D., explores the ways deep sleep improves cognition and resistance exercise boosts deep sleep. With a new grant, she is studying the best exercise prescription for people with Parkinson’s. -
New study uses electrical stimulation to treat depression
UAB is participating in a nationwide study to treat clinically depressed patients with a VNS device — originally created for treatment of seizure disorders. -
Will reduction in tau protein protect against Parkinson’s and Lewy body dementias?
New results suggest the answer is no, implying that the role of tau in the pathogenesis of Lewy body dementias is distinct from Alzheimer’s disease. -
Will reduction in tau protein protect against Parkinson’s and Lewy body dementias?
New results suggest the answer is no, implying that the role of tau in the pathogenesis of Lewy body dementias is distinct from Alzheimer’s disease. -
New Alzheimer’s drug not a panacea, but may slow worsening of the disease
The first new medication for Alzheimer’s disease in almost 20 years seems to reduce the amount of amyloid peptide in the brain, which may slow the progression of the disease. -
New Alzheimer’s drug not a panacea, but may slow worsening of the disease
The first new medication for Alzheimer’s disease in almost 20 years seems to reduce the amount of amyloid peptide in the brain, which may slow the progression of the disease. -
Harms Named 2021 Dean’s Excellence Award Winner in Research
Ashley Harms, Ph.D., assistant professor in the Department of Neurology, has been awarded the junior faculty 2021 Dean’s Excellence Award for Research. -
18 faculty members named winners of 2021 Dean’s Excellence Awards
Eighteen outstanding faculty members have been named winners of the 2021 Dean’s Excellence Awards in the areas of teaching, research, service, mentorship, and diversity. -
Chronic kidney disease a major factor for those taking anticoagulant medications
Physicians treating heart disease with anti-coagulants should factor the presence of kidney disease into their decisions on medications. -
What 10 mentors learned from teaching graduate students and postdocs
Ten graduate faculty were honored with the UAB Graduate Dean’s Excellence in Mentorship Award for exceptional work with graduate students and postdoctoral fellows. -
Gray elected to Hereditary Disease Foundation’s Scientific Board
The University of Alabama at Birmingham’s Dr. Michelle Gray has been elected to be a member on the Scientific Board of the Hereditary Disease Foundation. -
UAB undergrad earns scholarship to study novel therapy for ALS
The Gwen Claussen, M.D., ALS Research Fund was created to provide research opportunities for undergraduate students in the neurosciences. -
Caring for patients, Blazers through COVID-19
From doctors to chaplains to counselors, UAB employees supported patients, students and each other with compassionate care using telehealth, mental health apps, innovative testing strategies and more. -
School of Medicine tops $269 million in NIH funding for 2020
UAB received over $325 million in research funding from the National Institutes of Health (NIH) in 2020. -
More than 1,100 employees to be honored with annual service awards
This year, the university recognizes 50 years of service by Jeanne Hutchison, Ph.D., and Ferdinand Urthaler, M.D., and 45 years of service by Robert Kim M.D., and Joseph Lovetto. In addition, 294 employees with 20 or more years and 904 with five, 10 and 15 years will honored for their longevity. -
American Heart Association presents strategies to preserve brain health
Preserving brain health in an aging population is a growing concern in the United States. An estimated one in five Americans 65 years and older has mild cognitive impairment, and one in seven has dementia.
